Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 30, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

August 31, 2026

Conditions
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
Interventions
BEHAVIORAL

ADAPTS (ADherence Assessments and Personalized Timely Support).

ADAPTS is a mobile app intervention that integrates contextually-tailored mobile messages and decision rules about when to deliver the messages, with the ultimate goal of improving oral chemotherapy adherence in AYAs with acute lymphoblastic leukemia and lymphoma. AYA participants will be micro-randomized to receive messages on some days that are adapted to their current characteristics (e.g., mood, pain, location) and designed to promote adherence, and no messages (no intervention) on other days. Other features in the app include a medication calendar that syncs with the electronic medication monitor (eCAP) to track daily adherence. A caregiver version of ADAPTS is also available, providing daily surveys (but no randomized mobile messages) and the medication calendar so that dyads can mutually track adherence.

Trial Locations (1)

60611

RECRUITING

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT03932903 - Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia | Biotech Hunter | Biotech Hunter